Pharmacokinetic and bioequivalence study of Telzap® in comparison with Mikardis® in healthy subjects after single administrationl
Introduction. Telmisartan is widely used in clinical practice during hypertension treatment. It is a specific angiotensin II receptor antagonist (type AT1), effective at oral intake, A bioequivalence study of Telzap® and Mikardis® was conducted with 60 volunteers.Aim. The purpose of the bioequivalen...
Saved in:
Main Authors: | A. L. Khokhlov (Author), A. A. Khokhlov (Author), A. E. Miroshnikov (Author), O. V. Lebedeva (Author), D. Yu. Grebenkin (Author) |
---|---|
Format: | Book |
Published: |
LLC "Publisher OKI",
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic and bioequivalence study of Telzap® Plus fixed-dose combination compared with MikardisPlus® in healthy volunteers after single administration
by: A. L. Khokhlov, et al.
Published: (2023) -
Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects
by: A. L. Khokhlov, et al.
Published: (2022) -
Analysis of the quality of bioequivalence and pharmacokinetics studies in Russia Federation
by: A. L. Khokhlov, et al.
Published: (2018) -
Bioequivalence and Pharmacokinetics of Two Formulations of Amlodipine Tablets in Healthy Subjects
by: Jaafar J. Ibraheem Al-Tamimi
Published: (2017) -
Bioequivalence and Pharmacokinetics of Two Formulations of Amlodipine Tablets in Healthy Subjects
by: Jaafar J. Ibraheem Al-Tamimi
Published: (2017)